EAST LANSING, Mich. (News 10) – A team of researchers at Michigan State University has identified the protein responsible for making ovarian cancer cells resistant to chemotherapy — and found a way to reverse the process.
According to the American Cancer Society, more than 21,000 women will be diagnosed with ovarian cancer in 2026, and more than 12,000 will die from the disease.
The problem with chemo resistance
Chemotherapy is one of the primary treatments for cancer, but patients with ovarian cancer frequently stop responding to it. Sachi Horibata, an assistant professor at Michigan State University, said the rate of resistance is significant.
“But unfortunately for ovarian cancer, up to 80% of the patients will develop chemotherapy resistance,” Horibata said. “It’s really important [that] we can prevent resistance from happening to something that is so highly effective in the beginning; it’s just that it does not last long.”…